Merge Healthcare Licenses Zero Footprint Patent Portfolio From Heart Imaging Technologies
January 14 2014 - 7:00AM
Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of
clinical systems and innovations that seek to transform healthcare,
and Heart Imaging Technologies (Heart IT), an industry leader in
web-based medical image viewing and management solutions, today
announced they have entered into a non-exclusive patent license and
settlement agreement.
The agreement provides Merge with access to Heart IT's complete
portfolio of healthcare information patents, including its zero
footprint technologies, which provide access to diagnostic-quality
images in a standard web browser. The agreement also settles the
litigation initiated by Heart IT against Merge in September of 2012
for patent infringement related to internet-based image viewing. As
part of the settlement, Merge has agreed to not challenge the
validity or enforceability of Heart IT's zero footprint
patents.
"We're pleased to come to an agreement with Heart IT," said
Justin Dearborn, CEO at Merge Healthcare. "This settlement is a
positive one for Merge. We're now the only company, aside from
Heart IT, that can offer its customers a zero client viewer without
concern over infringing Heart IT's patents. The settlement also
creates new development opportunities for Merge to collaborate with
Heart IT on future solutions. We remain focused on providing
industry leading imaging solutions that enable advanced
interoperability across the enterprise and support standards and
regulatory initiatives such as Meaningful Use Stage 2."
"Heart IT's commitment to developing and patenting zero
footprint technologies dates back to the late 1990s," said Robert
M. Judd, Ph.D., President of Heart Imaging Technologies. "Now,
these technologies are revolutionizing image distribution to
referring physicians. We believe the next step is to allow
physicians to make primary diagnoses in a web browser, thereby,
reducing the need for expensive proprietary workstations. This
patent license agreement allows Heart IT to collaborate with Merge,
an established leader in advanced interoperability solutions, on
new products that reduce healthcare costs while simultaneously
improving patient care."
About Heart IT
Founded in 2000 and headquartered near North Carolina's Research
Triangle Park, Heart IT is a global leader in the medical image web
enablement field. Their flagship product, WebPAX(R) is the first
FDA approved zero foot-print medical image workstation. It provides
web-based medical image management technology and services to
healthcare systems, large hospitals and private clinics as well as
drug and device companies sponsoring multi-center clinical trials.
Worldwide, WebPAX(R) systems currently provide secure web browser
access to over one billion medical images. For more information
visit our website at http://www.heartit.com/.
About Merge
Merge is a leading provider of clinical systems and innovations
that seek to transform healthcare. Merge's enterprise and
cloud-based solutions for image intensive specialties provide
access to any image, anywhere, any time. Merge also provides
clinical trials software and other health data and analytics
solutions that engage consumers in their personal health. With
solutions that are used by providers and consumers and include more
than 25 years of innovation, Merge is helping to reduce costs and
improve the quality of healthcare worldwide. For more information,
visit merge.com.
CONTACT: Media Contacts:
Jennifer Jawor
Director, Corporate Marketing
Merge Healthcare
312.565.6825
jennifer.jawor@merge.com
Brent Reed, MBA
Chief Technology Officer
Heart Imaging Technologies
919.323.3001 ext 302
brent.reed@heartit.com
Mirage Energy (PK) (USOTC:MRGE)
Historical Stock Chart
From May 2024 to Jun 2024
Mirage Energy (PK) (USOTC:MRGE)
Historical Stock Chart
From Jun 2023 to Jun 2024